UOMI Cancer Center - Clinica Tres Torres
- Address
- c/ Dr Roux 76, 08017 Barcelona, Spain
UOMI Cancer Center - Clinica Tres Torres
UOMI Cancer Center at Clinica Tres Torres is a specialized oncology research facility dedicated to advancing treatment options for patients with advanced lung malignancies. The center participates in innovative clinical trials exploring novel therapeutic combinations and immunotherapy approaches for difficult-to-treat cancers.
- Second-line therapies for metastatic non-small-cell lung cancer
- Combination immunotherapy and chemotherapy strategies
- Treatment options following chemo-immunotherapy progression
The center's research portfolio emphasizes advanced NSCLC treatment pathways, investigating the efficacy of innovative combinations including peptide-based immunotherapies in conjunction with standard chemotherapy agents and checkpoint inhibitors. This work is particularly focused on addressing the critical needs of patients who have progressed on first-line treatment regimens.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Fondazione Ricerca Traslazionale1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in UOMI Cancer Center - Clinica Tres Torres
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase II Randomized Trial of Tedopi with Docetaxel or Nivolumab in Metastatic NSCLC Post-Chemoimmunotherapy | Fondazione Ricerca Traslazionale | Phase II | Recruiting | Feb 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala | 1 | Unknown | 2025-02-07 | 2025-02-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.